Related Experiment Video
Updated: Sep 14, 2025

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Inflammation-Related Factors S100A9 and TLR2 in Cardiomyocyte Hypertrophy
Ke-Jia Jin1, Le Pan1, Chen-Xing Huang1
1Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, and Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.
Insights
Inflammatory mediators S100A9 and Toll-like receptor 2 (TLR2) amplify heart failure progression through reciprocal activation, worsening cardiac remodeling and hypertrophy.
Area of Science:
- Cardiovascular Biology
- Immunology
- Molecular Medicine
Background:
- Heart failure (HF) pathogenesis involves complex pathways, including immune dysregulation and cardiac remodeling.
- Specific inflammatory mediators contribute to cardiac remodeling, but mechanisms are unclear.
Purpose of the Study:
- To investigate the role of immune-related genes in heart failure and hypertrophic cardiomyopathy.
- To elucidate the molecular mechanisms linking inflammation and cardiac hypertrophy.
Main Methods:
- Integrated bioinformatics analysis of HF and hypertrophic cardiomyopathy transcriptomic data.
- Construction of protein-protein interaction networks and module analysis.
- Validation using in vitro (mechanical stretch) and in vivo (transverse aortic constriction) models.
Main Results:
- Significant association found between immune function and cardiac remodeling.
- S100 calcium-binding protein A9 (S100A9) and Toll-like receptor 2 (TLR2) identified as key inflammatory factors.
- Elevated S100A9 in HF patients and cardiomyocytes correlated with hypertrophy markers; S100A9 upregulated TLR2, which was attenuated by inhibition.
Conclusions:
- S100A9 and TLR2 exhibit reciprocal activation, amplifying cardiomyocyte hypertrophy.
- This inflammatory cross-talk exacerbates maladaptive cardiac remodeling and HF progression.
Objective:
The pathogenesis and progression of heart failure (HF) are governed by complex, interconnected biological pathways, with dysregulated immune responses and maladaptive cardiac remodeling playing central roles. Although specific inflammatory mediators have been implicated in modulating critical features of cardiac remodeling-such as cardiomyocyte hypertrophy and extracellular matrix fibrosis-the precise molecular mechanisms driving these processes remain incompletely characterized.
Methods:
Integrated bioinformatics analysis of HF and hypertrophic cardiomyopathy (HCM) transcriptomic datasets identified pathologically relevant candidate genes. A protein-protein interaction (PPI) network was constructed from these candidates using the STRING database, followed by module analysis. Serum S100 calcium-binding protein A9 (S100A9) protein expression in HF patients was quantified by Western blotting under reducing conditions. The functional relevance of prioritized genes was subsequently validated through: (i) in vitro cyclic mechanical stretch in primary neonatal rat cardiomyocytes, and (ii) in vivo pressure overload modeling via transverse aortic constriction (TAC) in mice.
Results:
Bioinformatics analysis of HF and HCM datasets revealed a significant association between immune function and cardiac remodeling. Using CytoNCA, we identified core genes, among which the top 25 included multiple inflammatory pathway-related factors, such as S100A9 and Toll-like receptor 2 (TLR2). Notably, S100A9 levels were significantly elevated in the serum of HF patients and in mechanically stretched cardiomyocytes. This increase correlated with upregulated expression of hypertrophy-related markers, including atrial natriuretic peptide (ANP). Furthermore, mechanical stretch-induced S100A9 upregulation markedly enhanced TLR2 expression in cardiomyocytes. Importantly, TLR2 inhibition substantially attenuated the mechanical stretch-induced upregulation of S100A9 mRNA expression, as well as the subsequent hypertrophic and inflammatory responses in cardiomyocytes.
Conclusion:
The inflammatory mediators S100A9 and TLR2 engage in reciprocal activation that amplifies the hypertrophic response in mechanically stretched cardiomyocytes. This pathogenic cross-talk exacerbates maladaptive remodeling and likely accelerates HF progression.
Related Concept Videos
Myocarditis I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Rheumatic Heart Disease I: Introduction
Pathophysiology of Heart Failure

